Logo-bi
Editorial
Azam Safary ORCID, Mostafa Akbarzadeh Khiavi ORCID, Rahimeh Mousavi, Jaleh Barar ORCID, Mohammad A Rafi*
Bioimpacts. 2018;8(3): 153-157. doi: 10.15171/bi.2018.17
PMCID: PMC6128977     PMID: 30211074     Scopus ID: 85050655722    
Editorial
Yadollah Omidi ORCID, Abass Alavi* ORCID
BioImpacts. 2021;11(1): 1-4. doi: 10.34172/bi.2021.01
PMCID: PMC7803920     PMID: 33469502     Scopus ID: 85099192222    
Mohammad Rafi (Persian: محمد رفیع ) obtained his PhD from University of Montpellier, France, in 1970. Investigating lysosomal storage diseases, he focused on gene therapy of neurodegenerative disorders using globoid cell leukodystrophy (Krabbe disease) animal models. With successful AAVrh10-mediated therapy in animal models, his research is moving towards human clinical trials.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge